ストックスクリーナーアプリを入手
0.00
100.00%
-70.98
アフターアワーズ：
70.95
70.95
+
前日終値:
$70.98
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$3.63B
収益：
$431.90M
当期純損益:
$-5.66M
株価収益率:
0.00
EPS:
-0.25
ネットキャッシュフロー:
$5.37M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$71.05
Axonics Inc Stock (AXNX) Company Profile
AXNX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AXNX
Axonics Inc
|
0.00 | 3.63B | 431.90M | -5.66M | 5.37M | -0.1204 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Axonics Inc Stock (AXNX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-01-09 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-07-13 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-05-23 | 開始されました | CL King | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-03-24 | アップグレード | Needham | Hold → Buy |
| 2022-10-21 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-10-10 | ダウングレード | Needham | Buy → Hold |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-07-12 | 開始されました | Barclays | Overweight |
| 2021-06-28 | 繰り返されました | Needham | Buy |
| 2020-11-05 | 繰り返されました | Needham | Buy |
| 2020-10-23 | 開始されました | Guggenheim | Buy |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-07 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-11-01 | 開始されました | Piper Jaffray | Overweight |
| 2019-10-21 | 開始されました | Barclays | Overweight |
| 2019-09-17 | 開始されました | SVB Leerink | Outperform |
| 2019-09-09 | 繰り返されました | Needham | Buy |
| 2019-09-03 | 開始されました | Needham | Buy |
| 2019-06-13 | 繰り返されました | BofA/Merrill | Buy |
| 2018-11-26 | 開始されました | BofA/Merrill | Buy |
| 2018-11-26 | 開始されました | Morgan Stanley | Overweight |
| 2018-11-26 | 開始されました | SunTrust | Buy |
| 2018-11-26 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Axonics Inc (AXNX) 最新ニュース
Boston Scientific stock holds rating after Axonics acquisition - Investing.com
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors - PR Newswire UK
Boston Sci. Completes $3.7B Axonics Buy - Orange County Business Journal
Thibodaux Regional Urology Clinic Recognized as an Axonics® Center of Excellence - Lafourche Gazette
Boston Scientific Stock Set to Gain From Completion of Axonics Deal - MSN
Axonics, Inc. (NASDAQ:AXNX) Stock Holdings Raised by Alpine Associates Management Inc. - MarketBeat
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates - MSN
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific Completes Strategic Acquisition of Axonics - Zenopa
LMR Partners LLP Reduces Stock Holdings in Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Boston Scientific Completes Acquisition of Axonics - Zenopa
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific Closes Acquisition of Axonics - FinSMEs
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors - The Manila Times
Short Interest in Axonics, Inc. (NASDAQ:AXNX) Grows By 5.4% - MarketBeat
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific completes $3.7B purchase of California bowel dysfunction company - Worcester Business Journal
Boston Scientific finalizes $3.7B acquisition of Axonics - Mass Device
Boston Scientific closes $3.7B Axonics deal after lengthy review - MedTech Dive
Boston Sci Closes Acquisition of Medtronic’s Neuromodulation Foe - MD+DI
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific closes acquisition of Axonics, Inc - Med-Tech Innovation
Axonics Modulation Technologies Merges and Delists from Nasdaq - TipRanks
Axonics, Inc. Announces Management Changes - Marketscreener.com
Boston Scientific Completes $3.7B Axonics Acquisition, Expands Urology Portfolio | BSX Stock News - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Axonics stock soars to 52-week high, reaches $70.93 By Investing.com - Investing.com Australia
Axonics stock soars to 52-week high, reaches $70.93 - Investing.com India
Axonics gains after Nasdaq delisting notice for sale to Boston Scientific - MSN
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Versor Investments LP Sells 30,587 Shares of Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Axonics’ Q3 2024: Revenue Growth Amid Challenges - TipRanks
Axonics' (AXNX) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Axonics: Q3 Earnings Snapshot - Houston Chronicle
Axonics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Axonics Reports Third Quarter 2024 Financial Results - BioSpace
Axonics Inc (AXNX) Q3 2024 Earnings: Revenue Hits $116.2 Million, Surpassing Estimates - GuruFocus.com
Medtronic Says Axonics Misled Jury To Beat Patent Case - Law360
Axonics stock soars to 52-week high, reaches $70.6 - Investing.com
Axonics stock soars to 52-week high, reaches $70.6 By Investing.com - Investing.com UK
Axonics’ Market Growth Strengthens Boston Scientific’s Future (NASDAQ:AXNX) - Seeking Alpha
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Shares Sold by Oak Ridge Investments LLC - MarketBeat
Axonics Inc (AXNX) 財務データ
収益
当期純利益
現金流量
EPS
1.54%
大文字化:
|
ボリューム (24 時間):